Fang Ni

Insider Reports History

Location
Cambridge, MA
Signature
/s/ Brent Hatzis-Schoch, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Fang Ni:

Company Role Class Num Shares Value Price $ Report Date Ownership
Black Diamond Therapeutics, Inc. Officer Title: Chief Business Officer and Chief Financial Officer Stock Option (Right to Buy) 200,000 14 Feb 2024 Direct

Insider Reports Filed by Fang Ni

Symbol Company Period Transactions Value $ Form Type Role Filing Time
BDTX Black Diamond Therapeutics, Inc. 14 Feb 2024 1 $0 4 Officer Title: Chief Business Officer and Chief Financial Officer 15 Feb 2024, 17:45
BDTX Black Diamond Therapeutics, Inc. 13 Feb 2023 1 $0 4 Officer Title: Chief Business Officer and interim Chief Financial Officer 15 Feb 2023, 15:11
BDTX Black Diamond Therapeutics, Inc. 21 Dec 2022 2 +$72,366 4 Officer Title: Chief Business Officer and interim Chief Financial Officer 23 Dec 2022, 15:23
BDTX Black Diamond Therapeutics, Inc. 29 Jun 2022 1 +$61,018 4 Officer Title: Chief Business Officer and interim Chief Financial Officer 30 Jun 2022, 16:05
BDTX Black Diamond Therapeutics, Inc. 15 Feb 2022 1 $0 4 Officer Title: Chief Business Officer and interim Chief Financial Officer 17 Feb 2022, 15:15
BDTX Black Diamond Therapeutics, Inc. 18 Nov 2021 0 $0 3 Officer Title: Chief Business Officer and interim Chief Financial Officer 29 Nov 2021, 20:23